Snowwater Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
4,107
+289
+8% +$62.2K 0.71% 30
2026
Q1
$830K Sell
3,818
-161
-4% -$35.7K 0.78% 33
2025
Q4
$909K Buy
+3,979
New +$906K 0.84% 29

Other funds holding ABBV

Snowwater Investment Partners's ABBV Position: Q2 2026 in Review

Snowwater Investment Partners increased its AbbVie (ABBV) stake by 7.6% in Q2 2026, buying an estimated $62.2K and bringing the position to 4,107 shares worth $1.03M. The position accounts for 0.71% of the portfolio, ranked #30.

Snowwater Investment Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Snowwater Investment Partners held 4,107 shares of AbbVie worth $1.03M as of Q2 2026.
  • Snowwater Investment Partners bought 289 AbbVie shares in Q2 2026, an estimated $62.2K.
  • AbbVie made up 0.71% of Snowwater Investment Partners's portfolio in Q2 2026, its #30 holding.
  • Snowwater Investment Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Snowwater Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.